Utility of Cortical Bone Tissue Properties in the Assessment of Fracture Risk

NAActive, not recruitingINTERVENTIONAL
Enrollment

190

Participants

Timeline

Start Date

January 26, 2015

Primary Completion Date

August 8, 2026

Study Completion Date

November 30, 2028

Conditions
Distal Radius FractureOsteoporosisHip Fractures
Interventions
DEVICE

Reference Point Indentation

"The Osteoprobe: Since these first reports of indentation measurements in humans in vivo, a more 'user-friendly' device, the Osteoprobe® has been developed by Active Life Scientific (Santa Barbara, CA) (10). The Osteoprobe®, which we will use in the current study, is smaller than the previous reference point indentation (RPI) instrument and is designed to be used in a hand-held fashion to allow for rapid measurements. The new instrument does not require a reference probe, because the inertia of the instrument keeps it adequately fixed in space during the short time of the indentation impact (\~0.25 milliseconds). The main parameter measured is the distance that the probe further indents into the bone from the reference point. Key components of the Osteoprobe® include an impact generation mechanism, a displacement transducer, and a probe made of hardened stainless steel with a 90 degree conical tip, with a tip diameter of \~375 µm."

Trial Locations (1)

02215

Beth Israel Deaconess Medical Center, Boston

All Listed Sponsors
collaborator

Brigham and Women's Hospital

OTHER

lead

Beth Israel Deaconess Medical Center

OTHER

NCT03076034 - Utility of Cortical Bone Tissue Properties in the Assessment of Fracture Risk | Biotech Hunter | Biotech Hunter